<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05620758</url>
  </required_header>
  <id_info>
    <org_study_id>TMD_Laser_2022</org_study_id>
    <nct_id>NCT05620758</nct_id>
  </id_info>
  <brief_title>Laser Therapy and Temporomandibular Disorders</brief_title>
  <official_title>Clinical Effectiveness of a Laser Therapy in Patients With Temporomandibular Disorders (A Randomized Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hams Hamed Abdelrahman</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      TMD involves a set of multiple clinical manifestations where the pain is prevalent. Treatment&#xD;
      ideally should be noninvasive and innocuous such as photobiomodulation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2022</start_date>
  <completion_date type="Anticipated">January 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain</measure>
    <time_frame>Baseline and 1 month</time_frame>
    <description>Visual analogue scale of pain (VAS),using a 0-10-point scale 0 score means no pain&quot; and score 10 means &quot;worst pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chaneg in pressure pain threshold</measure>
    <time_frame>Baseline and 1 month</time_frame>
    <description>The pressure pain threshold measurements for the trapezius, infraspinatus, and extensor carpi radialis muscles were performed at the center of the upper trapezius, at a position 2-3 fingers below the center of the spine of scapula, and at a position 3-4 fingers below the lateral epicondyle of the humerus, respectively. The pressure pain threshold of the extensor indicis proprius was measured by pressing toward the medial side of the radius from a position 3 fingers above the radial styloid process. The investigator placed the digital pressure algometer on a site to be inspected and pressed against the tester in a vertical direction while increasing the force at a constant rate of 1 kg/cm2. The investigator instructed the subjects to express pain either by saying &quot;ouch&quot; or raising their hands when only slight pain was felt. After all 8 muscles were investigated, the subjects were allowed to rest for 5 min. This procedure was repeated a total of 3 times.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Oral-health Related Quality of life (OHRQoL)</measure>
    <time_frame>Baseline and 1 month</time_frame>
    <description>The OHIP-14 has 14 questions related to the evaluation of OHRQoL. The responses were recorded in a 5-point Likert scale ranging from never to very often (score is 0 to 4). Then, we calculated the total scores of all domains, and a higher score indicated poor OHRQoL. The highest possible total score of all the OHIP-14 domains is 56</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>TMD</condition>
  <arm_group>
    <arm_group_label>Nd YAG laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diode laser 980 nm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diode laser 940 nm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diode laser 660 nm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diode laser 635 nm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nd YAG laser</intervention_name>
    <description>patients from those diagnosed with TMD will receive Nd YAG laser 1064 nm</description>
    <arm_group_label>Nd YAG laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diode laser (980 nm)</intervention_name>
    <description>patients from those diagnosed with TMD will receive a diode laser (980 nm)</description>
    <arm_group_label>Diode laser 980 nm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diode laser (940 nm)</intervention_name>
    <description>patients from those diagnosed with TMD will receive a diode laser (940 nm)</description>
    <arm_group_label>Diode laser 940 nm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diode laser (660 nm)</intervention_name>
    <description>patients from those diagnosed with TMD will receive a diode laser (660 nm)</description>
    <arm_group_label>Diode laser 660 nm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diode laser (635 nm)</intervention_name>
    <description>patients from those diagnosed with TMD will receive a diode laser (635 nm)</description>
    <arm_group_label>Diode laser 635 nm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pain at TMJ area.&#xD;
&#xD;
          -  Pain at masseter and temporalis muscles.&#xD;
&#xD;
          -  Age ranges between 20 and 40 years old.&#xD;
&#xD;
          -  Presence of full or nearly full complement of natural teeth&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have radiographic evidence of degenerative conditions of TMJ.&#xD;
&#xD;
          -  Patients under current dental or physical therapy that could affect TMD.&#xD;
&#xD;
          -  History of recent trauma.&#xD;
&#xD;
          -  The presence of systemic diseases (i.e. rheumatoid arthritis, osteoarthritis).&#xD;
&#xD;
          -  Pregnant and lactating females&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nermeen A Rady, phd</last_name>
    <phone>01223349577</phone>
    <email>nermeen.rady@alexu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alexandria Faculty of Dentistry</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nermeen A Rady, phd</last_name>
      <email>Abdallah.abdelaty@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nermeen A Rady, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariam M Bahgat, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2022</verification_date>
  <study_first_submitted>November 10, 2022</study_first_submitted>
  <study_first_submitted_qc>November 10, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>December 11, 2022</last_update_submitted>
  <last_update_submitted_qc>December 11, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Hams Hamed Abdelrahman</investigator_full_name>
    <investigator_title>Assistant lecturer of DPH and Clinical statistician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

